Download PDF
Exp Clin Endocrinol Diabetes 2018; 126(09): 584-589
DOI: 10.1055/a-0653-7135
Article
© Georg Thieme Verlag KG Stuttgart · New York

Metabolic Determinants of Impaired Pulmonary Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Martin Röhling
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
3   West-German Center of Diabetes and Health, Düsseldorf Catholic Hospital Group, Düsseldorf, Germany
,
Dominik Pesta
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
,
Daniel F. Markgraf
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
,
Klaus Strassburger
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
4   Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
Birgit Knebel
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
5   Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
Volker Burkart
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
,
Julia Szendroedi
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
6   Divison of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
Karsten Müssig   *
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
6   Divison of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
Michael Roden   *
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   German Center for Diabetes Research (DZD), München-Neuherberg, Germany
6   Divison of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
for the GDS study group › Author Affiliations
Further Information

Publication History

received 11 December 2017
revised 11 June 2018

accepted 04 July 2018

Publication Date:
24 August 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Aims Impaired lung function associates with deterioration of glycemic control and diabetes-related oxidative stress in long-standing type 2 diabetes. We hypothesized that recent-onset type 2 diabetes patients exhibit abnormal pulmonary function when compared to glucose-tolerant controls and that the frequencies of single-nucleotide polymorphisms (SNPs), known to associate with lung dysfunction, are different between both groups.

Methods Type 2 diabetes patients with a known disease duration<1 year (n=34) had similar age, sex distribution and BMI as overweight controls (n=26). Lung function was assessed by spirometry comprising predicted forced vital capacity (FVC%), predicted forced expiratory volume in one second (FEV1%) and the FEV1/FVC ratio. Multivariable linear regressions were performed to investigate group differences, which were adjusted for potential confounders such as age, sex, BMI, height and smoking status. SNP genotyping was conducted using real-time polymerase chain reaction-based allelic discrimination.

Results Patients with type 2 diabetes had lower FEV1%, FEV1/FVC and VO2max (all p<0.05). Among patients with type 2 diabetes, FEV1% correlated positively with VO2max (r=0.40, p<0.05) and FEV1/FVC correlated negatively with HbA1c (r=−0.49, p<0.01). Regression analyses across the whole cohort indicated that the group differences in FEV1/FVC can be explained by the confounding effect of HbA1c. The frequencies of the SNPs rs1042713, rs1079572, rs11172113, rs12504628, rs1422795, rs1481345, rs2235910, rs2277027, rs2284746, rs4341, rs7068966, rs925284, rs993925 and rs3824658 did not differ between both groups.

Conclusions Recent-onset type 2 diabetes patients exhibit reductions in features of pulmonary function, which might be at least in part resulting from glucotoxicity.

Key words

diabetes complications - lung - single nucleotide polymorphisms - HbA1c

* Equal contribution.


# The GDS Group consists of A.E. Buyken, J. Eckel, G. Geerling, H. Al-Hasani, C. Herder, A. Icks, J. Kotzka, O. Kuss, E. Lammert, D. Markgraf, K. Müssig, W. Rathmann, J. Szendrödi, D. Ziegler and M. Roden (speaker).


Supplementary Material

 

  • References

  • 1 Hole DJ, Watt GC, Davey-Smith G. et al. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-716
    CrossrefPubMedGoogle Scholar
  • 2 Yeh HC, Punjabi NM, Wang N. et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31: 741-746
    CrossrefPubMedGoogle Scholar
  • 3 Klein OL, Kalhan R, Williams MV. et al. Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes. Diabet Med 2012; 29: 212-219
    CrossrefPubMedGoogle Scholar
  • 4 Ehrlich SF, Quesenberry CP, Van Denn Eeden SK. et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60
    CrossrefPubMedGoogle Scholar
  • 5 Fuso L, Pitocco D, Condoluci C. et al. Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus. Eur J Intern Med 2015; 26: 273-278
    CrossrefPubMedGoogle Scholar
  • 6 Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289-330
    CrossrefPubMedGoogle Scholar
  • 7 Dennis RJ, Maldonado D, Rojas M. et al. Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: A cross-sectional study. BMC Pulm Med 2010; 10: 38
    CrossrefPubMedGoogle Scholar
  • 8 Kinney GL, Black-Shinn JL, Wan ES. et al. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care 2014; 37: 389-395
    CrossrefPubMedGoogle Scholar
  • 9 Wilk JB, Djousse L, Arnett DK. et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000; 19: 81-94
    CrossrefPubMedGoogle Scholar
  • 10 Hancock DB, Eijgelsheim M, Wilk J. et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010; 42: 45-52
    CrossrefPubMedGoogle Scholar
  • 11 Zhao XP, Liao M, Chang S. et al. Maternal diabetes modulates kidney formation in murine progeny: The role of hedgehog interacting protein (HHIP). Diabetologia 2014; 57: 1986-1996
    CrossrefPubMedGoogle Scholar
  • 12 Weerasekera L, Rudnicka C, Sang Q. et al. ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice. Mediators Inflamm 2017; 2017: 9
    PubMedGoogle Scholar
  • 13 Prior SJ, Goldberg AP, Ryan AS. ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women. Obesity 2011; 19: 396-401
    CrossrefPubMedGoogle Scholar
  • 14 Craft CS, Pietka TA, Schappe T. et al. The extracellular matrix protein MAGP1 supports thermogenesis and protects against obesity and diabetes through regulation of TGF-beta. Diabetes 2014; 63: 1920-1932
    CrossrefPubMedGoogle Scholar
  • 15 Ronn T, Volkov P, Gillberg L. et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum Mol Genet 2015; 24: 3792-3813
    PubMedGoogle Scholar
  • 16 Sakai K, Imamura M, Tanaka Y. et al. Replication study for the association of 9 East Asian GWAS-derived loci with susceptibility to type 2 diabetes in a Japanese population. PLoS One 2013; 8: e76317
    CrossrefPubMedGoogle Scholar
  • 17 Davis WA, Brown SG, Jacobs IG. et al. Angiotensin-converting enzyme insertion/deletion polymorphism and severe hypoglycemia complicating type 2 diabetes: The Fremantle Diabetes Study. J Clin Endocrinol Metab 2011; 96: E696-E700
    CrossrefPubMedGoogle Scholar
  • 18 Chang SY, Chen YW, Zhao XP. et al. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012; 61: 2565-2574
    CrossrefPubMedGoogle Scholar
  • 19 Simonis-Bik AM, Nijpels G, van Haeften TW. et al. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010; 59: 293-301
    CrossrefPubMedGoogle Scholar
  • 20 Liu CC, Hu J, Tsai C. et al. Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci 2015; 35: 5851-5859
    CrossrefPubMedGoogle Scholar
  • 21 Rondas D, Crèvecoeur I, D'Hertog W. et al. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes 2015; 64: 573-586
    CrossrefPubMedGoogle Scholar
  • 22 Anjaneyulu M, Berent-Spillson A, Inoue T. et al. Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy. Exp Neurol 2008; 211: 469-479
    CrossrefPubMedGoogle Scholar
  • 23 Szendroedi J, Saxena A, Weber KS. et al. Cohort profile: The German Diabetes Study (GDS). Cardiovasc Diabetol 2016; 15: 59
    CrossrefPubMedGoogle Scholar
  • 24 Laukkanen JA, Kurl S, Salonen JT. et al. Peak oxygen pulse during exercise as a predictor for coronary heart disease and all cause death. Heart 2006; 92: 1219-1224
    CrossrefPubMedGoogle Scholar
  • 25 American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277
    CrossrefPubMedGoogle Scholar
  • 26 Yamane T, Yokohama A, Kitahara Y. et al. Cross-sectional and prospective study of the association between lung function and prediabetes. BMJ open 2013; 3: pii-e002179
    PubMedGoogle Scholar
  • 27 Hickson DA, Burchfiel CM, Liu J. et al. Diabetes, impaired glucose tolerance, and metabolic biomarkers in individuals with normal glucose tolerance are inversely associated with lung function: The Jackson Heart Study. Lung 2011; 189: 311-321
    CrossrefPubMedGoogle Scholar
  • 28 Luijks HD, de Grauw WJ, Bor J. et al Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: A prospective observational study in general practice. NPJ Prim Care Respir Med 2015; 25: 15032
    CrossrefPubMedGoogle Scholar
  • 29 Oh IH, Park JH, Lee CH. et al. The association of normal range glycated hemoglobin with restrictive lung pattern in the general population. PLoS One 2015; 10: e0117725
    CrossrefPubMedGoogle Scholar
  • 30 Jakes RW, Day NE, Patel B. et al. Physical inactivity is associated with lower forced expiratory volume in 1 second: European Prospective Investigation into Cancer-Norfolk Prospective Population Study. Am J Epidemiol 2002; 156: 139-147
    CrossrefPubMedGoogle Scholar
  • 31 Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2011; 8: 92-103
    PubMedGoogle Scholar
  • 32 Collins AR, Raslova K, Somorovska M. et al. DNA damage in diabetes: Correlation with a clinical marker. Free Radic Biol Med 1998; 25: 373-377
    CrossrefPubMedGoogle Scholar
  • 33 Kim SJ, Cheresh P, Jablonski RP. et al. Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage. Free Radic Biol Med 2016; 101: 482-490
    CrossrefPubMedGoogle Scholar
  • 34 Roberto S, Crisafulli A. Consequences of Type 1 and 2 Diabetes Mellitus on the Cardiovascular Regulation During Exercise: A Brief Review. Curr Diabetes Rev 2017; 13: 560-565
    PubMedGoogle Scholar
  • 35 Guazzi M, Belletti S, Bianco E. et al. Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: Different results with cardioversion. Am J Physiol Heart Circ Physiol 2006; 29: 921-928
    PubMedGoogle Scholar
  • 36 Baldi JC, Aoina JL, Oxenham HC. et al. Reduced exercise arteriovenous O2 difference in Type 2 diabetes. J Appl Physiol (1985) 2003; 94: 1033-1038
    CrossrefPubMedGoogle Scholar